Phase 1 study of sorafenib and hepatic arterial infusion chemotherapy with Miriplatin for advanced Hepatocellular carcinoma.
Phase of Trial: Phase I
Latest Information Update: 13 Sep 2016
At a glance
- Drugs Miriplatin (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 31 Aug 2016 Status changed from not yet recruiting to completed.
- 05 Sep 2012 New trial record